GlassScriptPhysician profile
Stephanie C Lee
NPI 1619030558
$10,602.25
in general payments reported to CMS, 2019-2025
30 companies · $689 in 2025
The $689 reported for 2025 was more than what 80% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $256 · 2021: $589 · 2022: $611 · 2023: $912 · 2024: $7,183 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,158 · Food and Beverage: $2,008 · Travel and Lodging: $1,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,158.23 |
| Food and Beverage | $2,007.78 |
| Travel and Lodging | $1,617.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,739.70 | 2023-2024 | Da Vinci Surgical System |
| Abbvie INC. | $540.16 | 2019-2023 | |
| Hologic Sales and Service, LLC | $533.93 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Astellas Pharma US INC | $446.21 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $268.15 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $221.64 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $217.67 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $206.20 | 2021-2023 | |
| Myovant Sciences INC. | $147.50 | 2021-2022 | |
| Galderma Laboratories, L.P. | $141.17 | 2020-2021 | |
| Therapeuticsmd, INC. | $135.00 | 2019-2022 | |
| Agile Therapeutics, INC. | $116.32 | 2021-2024 | Twirla |
| Lupin INC. | $96.44 | 2019-2020 | |
| Gynesonics, INC. | $96.27 | 2021 | |
| Millicent US INC | $85.56 | 2024-2025 | Intrarosa, Femring, Femlyv |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $79.14 | 2023 | Bracanalysis Cdx |
| Organon LLC | $76.25 | 2024-2025 | Nexplanon |
| Myriad Genetic Laboratories, INC. | $54.38 | 2025 | Prolaris |
| Allergan, INC. | $48.83 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $48.58 | 2021-2022 | |
| Zyla Life Sciences, INC. | $48.54 | 2020 | |
| Exact Sciences Corporation | $39.98 | 2025 | The Cologuard Plus Collection Kit |
| Olympus America INC. | $39.86 | 2022 | |
| Pfizer INC. | $37.18 | 2022-2023 | |
| Avion Pharmaceuticals | $36.30 | 2019-2021 | |
| Ethicon US, LLC | $30.58 | 2022 | |
| Daiichi Sankyo INC. | $26.07 | 2025 | Injectafer |
| Duchesnay USA Incorporated | $17.50 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.91 | 2019 | |
| Boston Scientific Corporation | $13.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.